As upregulated glutamine catabolism is essential for tumor but dispensable for normal cells, inhibiting enzymes like GOT1 in the glutamine catabolic pathway leads to increased levels of reactive oxygen species (ROS), reducing the levels of GSH and ultimately inhibiting tumor growth [133]. This evidence concerns the gene GOT1 and neoplasm.